Retraction notices

EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS

Type

Retraction

Notice date

4/30/2022 0:00

Journal

Inflammatory Bowel Diseases

Publisher

Crohn's & Colitis Foundation

Notice DOI

10.1093/ibd/izac055

Original paper DOI

10.1093/ibd/izac015.180

Reasons

• Notice - Limited or No Information
• Removed

Matching venue names

Name match only, not an authoritative journal identifier.

• Inflammatory Bowel Diseases